rethinkPeptides Search
Menu
Research citation

Subcutaneously administered tirzepatide vs semaglutide for adults with type 2 diabetes: a systematic review and network meta-analysis of randomised controlled trials.

evidence

This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.

Read the original research

Subcutaneously administered tirzepatide vs semaglutide for adults with type 2 diabetes: a systematic review and network meta-analysis of randomised controlled trials.

Diabetologia, 67(7), 1206-1222

Citation

Karagiannis, Thomas; Malandris, Konstantinos; Avgerinos, Ioannis; Stamati, Athina; Kakotrichi, Panagiota; Liakos, Aris; Vasilakou, Despoina; Kakaletsis, Nikolaos; Tsapas, Apostolos; Bekiari, Eleni. (2024). Subcutaneously administered tirzepatide vs semaglutide for adults with type 2 diabetes: a systematic review and network meta-analysis of randomised controlled trials.. Diabetologia, 67(7), 1206-1222. https://doi.org/10.1007/s00125-024-06144-1